Careers  |  Sign In  |  Register

Latest in Emergency Medicine

An article in the Los Angeles Times explains that while the average wait time for patients receiving angioplasty has dropped 20%, survival rates are not improving. About 10 years ago, "the American College of Cardiology and the American Heart Assn. began instituting guidelines to help hospitals reduce their...
The FDA has issued a warning for the drug Gilenya, manufactured by Novartis, approved for the treatment of multiple sclerosis, after a patient died within 24 hours of their first dose due to a brain infection. The FDA has reported that the patient was also being treated with beta blockers and calcium...
The New York Times' Well blog reports on a study in the Journal of Endodontics that is 9 year longitudinal study on hospitalizations due to periapical abcesses. According to the study, between 2000 and 2009, "a total of 61,439 hospitalizations were primarily attributed to periapical abscesses in the...